- Home
- HBNC vs IDYA Comparison
HBNC vs IDYA Comparison
Compare HBNC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBNC
- IDYA
- Stock Information
- Founded
- HBNC 1873
- IDYA 2015
- Country
- HBNC United States
- IDYA United States
- Employees
- HBNC N/A
- IDYA N/A
- Industry
- HBNC Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- HBNC Finance
- IDYA Health Care
- Exchange
- HBNC Nasdaq
- IDYA Nasdaq
- Market Cap
- HBNC 648.7M
- IDYA 2.6B
- IPO Year
- HBNC N/A
- IDYA 2019
- Fundamental
- Price
- HBNC $15.36
- IDYA $30.47
- Analyst Decision
- HBNC Hold
- IDYA Strong Buy
- Analyst Count
- HBNC 3
- IDYA 10
- Target Price
- HBNC $15.33
- IDYA $56.00
- AVG Volume (30 Days)
- HBNC 170.8K
- IDYA 997.5K
- Earning Date
- HBNC 10-23-2024
- IDYA 11-05-2024
- Dividend Yield
- HBNC 4.14%
- IDYA N/A
- EPS Growth
- HBNC N/A
- IDYA N/A
- EPS
- HBNC 0.43
- IDYA N/A
- Revenue
- HBNC $179,998,000.00
- IDYA $11,961,000.00
- Revenue This Year
- HBNC N/A
- IDYA N/A
- Revenue Next Year
- HBNC $7.84
- IDYA $94.96
- P/E Ratio
- HBNC $35.81
- IDYA N/A
- Revenue Growth
- HBNC N/A
- IDYA N/A
- 52 Week Low
- HBNC $9.22
- IDYA $23.41
- 52 Week High
- HBNC $16.64
- IDYA $47.74
- Technical
- Relative Strength Index (RSI)
- HBNC 53.38
- IDYA 41.00
- Support Level
- HBNC $14.44
- IDYA $28.69
- Resistance Level
- HBNC $14.83
- IDYA $31.54
- Average True Range (ATR)
- HBNC 0.39
- IDYA 1.42
- MACD
- HBNC -0.01
- IDYA 0.17
- Stochastic Oscillator
- HBNC 76.67
- IDYA 56.51
About HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.